🎯 check Hydroxyurea product page
Hydroxyurea is a reversible RNR inhibitor. It affects p53 and mTOR pathways by depleting dNTP pools, inhibiting DNA synthesis.
Hydroxyurea MOA:Targeting Ribonucleotide Reductase/NO-cGMP Signaling Pathway for Sickle Cell Disease
🎯 check Hydroxyurea product page
Hydroxyurea is a reversible RNR inhibitor. It affects p53 and mTOR pathways by depleting dNTP pools, inhibiting DNA synthesis.